Osaic Holdings
TAK icon

Osaic Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Osaic Holdings’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Sell
19,563
-10,693
-35% -$177K ﹤0.01% 4058
2026
Q1 		$560K Buy
30,256
+16,289
+117% +$286K ﹤0.01% 3233
2025
Q4 		$218K Sell
13,967
-6,875
-33% -$98.3K ﹤0.01% 4083
2025
Q3 		$307K Sell
20,842
-34
-0.2% -$505 ﹤0.01% 3848
2025
Q2 		$320K Buy
20,876
+8,502
+69% +$126K ﹤0.01% 3542
2025
Q1 		$184K Sell
12,374
-6,390
-34% -$89.5K ﹤0.01% 3702
2024
Q4 		$248K Sell
18,764
-2,049
-10% -$28.1K ﹤0.01% 3410
2024
Q3 		$296K Sell
20,813
-689
-3% -$9.77K ﹤0.01% 3321
2024
Q2 		$278K Buy
21,502
+725
+3% +$9.6K ﹤0.01% 3281
2024
Q1 		$288K Sell
20,777
-75,618
-78% -$1.1M ﹤0.01% 3369
2023
Q4 		$1.38M Sell
96,395
-47,337
-33% -$672K ﹤0.01% 2196
2023
Q3 		$2.22M Buy
143,732
+38,331
+36% +$593K ﹤0.01% 1898
2023
Q2 		$1.66M Buy
105,401
+3,842
+4% +$63K ﹤0.01% 2043
2023
Q1 		$1.67M Buy
101,559
+3,951
+4% +$62.9K ﹤0.01% 1983
2022
Q4 		$1.52M Buy
97,608
+3,256
+3% +$45.5K ﹤0.01% 1974
2022
Q3 		$1.22M Sell
94,352
-9,922
-10% -$138K ﹤0.01% 2036
2022
Q2 		$1.46M Buy
104,274
+5,657
+6% +$80.8K ﹤0.01% 1916
2022
Q1 		$1.93M Sell
98,617
-3,553
-3% -$52.2K ﹤0.01% 1945
2021
Q4 		$1.39M Sell
102,170
-16,932
-14% -$238K ﹤0.01% 2091
2021
Q3 		$1.96M Sell
119,102
-7,010
-6% -$118K ﹤0.01% 1721
2021
Q2 		$2.12M Buy
126,112
+19,518
+18% +$332K ﹤0.01% 1656
2021
Q1 		$1.95M Buy
106,594
+12,906
+14% +$232K ﹤0.01% 1646
2020
Q4 		$1.7M Buy
93,688
+13,314
+17% +$234K ﹤0.01% 1577
2020
Q3 		$1.43M Buy
80,374
+11,634
+17% +$212K ﹤0.01% 1564
2020
Q2 		$1.23M Buy
68,740
+1,923
+3% +$34.5K ﹤0.01% 1596
2020
Q1 		$1.02M Buy
+66,817
New +$1.21M ﹤0.01% 1525

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Osaic Holdings's TAK Position: Q2 2026 in Review

Osaic Holdings reduced its Takeda Pharmaceutical (TAK) stake by 35% in Q2 2026, selling an estimated $177K and leaving 19,563 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #4058.

Osaic Holdings first reported a position in TAK in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.22M in Q3 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Osaic Holdings held 19,563 shares of Takeda Pharmaceutical worth $314K as of Q2 2026.
  • Osaic Holdings sold 10,693 Takeda Pharmaceutical shares in Q2 2026, an estimated $177K.
  • Takeda Pharmaceutical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4058 holding.
  • Osaic Holdings first reported a position in Takeda Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Takeda Pharmaceutical position peaked at $2.22M in Q3 2023.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.